Why the study?
Does intraperitoneal delivery of SOD2-upregulated mesenchymal stem cells improve glucose tolerance and reduce adiposity in obese diabetic mice?
Population
Human adipose tissue-derived and bone marrow-derived mesenchymal stem cells; obese diabetic mice.
Comparison
Intraperitoneal delivery of 1.5 million human… vs Intraperitoneal delivery of human mesenchymal…
Design
Preclinical
Follow-up
4 weeks
Authors
Loading...
Hypothesis-generating in obese diabetic mice; leaves open clinical translation of SOD2-MSCs.
Does intraperitoneal delivery of SOD2-upregulated mesenchymal stem cells improve glucose tolerance and reduce adiposity in obese diabetic mice?
Delivery of superoxide dismutase (SOD2) using mesenchymal stem cells as a gene delivery vehicle reduces inflammation, body weight, and improves glucose tolerance in a diabetic mouse model.
Sen et al. (2015) studied this question.